Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Gorse

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Soins; La Revue De Reference Infirmiere|February 1, 1985
[Mycology technics]Y Donati, G Gorse
Journal of Interferon Research|August 1, 1986
The effect of hydrocortisone on the production of gamma-interferon and other lymphokines by human peripheral blood mononuclear cellsT C Cesario, L Slater, W J Poo, et al.
AIDS Research and Human Retroviruses|August 1, 1992
Specific activation strategies for amplification of low CTL signalsK J Weinhold, J Tartaglia, E Paoletti, et al.
The Journal of Infectious Diseases|February 18, 1998
Cytotoxic T cell and neutralizing antibody responses to human immunodeficiency virus type 1 envelope with a combination vaccine regimen. AIDS Vaccine Evaluation GroupL Corey, M J McElrath, K Weinhold, et al.
Lancet (London, England)|July 10, 1993
Induction of HIV-1-neutralising and syncytium-inhibiting antibodies in uninfected recipients of HIV-1IIIB rgp120 subunit vaccineD H Schwartz, G Gorse, M L Clements, et al.
The Journal of Infectious Diseases|August 1, 1997
Genetic and immunologic characterization of viruses infecting MN-rgp120-vaccinated volunteersP W Berman, A M Gray, T Wrin, et al.
AIDS (London, England)|May 1, 1994
Comparison of the immune response to recombinant gp120 in humans and chimpanzeesP W Berman, D J Eastman, D M Wilkes, et al.
AIDS Research and Human Retroviruses|June 30, 2000
A phase II study of two HIV type 1 envelope vaccines, comparing their immunogenicity in populations at risk for acquiring HIV type 1 infection. AIDS Vaccine Evaluation GroupM J McElrath, L Corey, D Montefiori, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Soins; La Revue De Reference Infirmiere|February 1, 1985
[Mycology technics]Y Donati, G Gorse
Journal of Interferon Research|August 1, 1986
The effect of hydrocortisone on the production of gamma-interferon and other lymphokines by human peripheral blood mononuclear cellsT C Cesario, L Slater, W J Poo, et al.
AIDS Research and Human Retroviruses|August 1, 1992
Specific activation strategies for amplification of low CTL signalsK J Weinhold, J Tartaglia, E Paoletti, et al.
The Journal of Infectious Diseases|February 18, 1998
Cytotoxic T cell and neutralizing antibody responses to human immunodeficiency virus type 1 envelope with a combination vaccine regimen. AIDS Vaccine Evaluation GroupL Corey, M J McElrath, K Weinhold, et al.
Lancet (London, England)|July 10, 1993
Induction of HIV-1-neutralising and syncytium-inhibiting antibodies in uninfected recipients of HIV-1IIIB rgp120 subunit vaccineD H Schwartz, G Gorse, M L Clements, et al.
The Journal of Infectious Diseases|August 1, 1997
Genetic and immunologic characterization of viruses infecting MN-rgp120-vaccinated volunteersP W Berman, A M Gray, T Wrin, et al.
AIDS (London, England)|May 1, 1994
Comparison of the immune response to recombinant gp120 in humans and chimpanzeesP W Berman, D J Eastman, D M Wilkes, et al.
AIDS Research and Human Retroviruses|June 30, 2000
A phase II study of two HIV type 1 envelope vaccines, comparing their immunogenicity in populations at risk for acquiring HIV type 1 infection. AIDS Vaccine Evaluation GroupM J McElrath, L Corey, D Montefiori, et al.
Pageof 1